Bonolive® (Olive Leaf Oleuropein — BioActor)

Bonolive® is a standardized olive (Olea europaea) leaf extract from BioActor, concentrated for oleuropein, the main polyphenol in olive leaves. It is studied for supporting bone health in postmenopausal women and for joint function, drawing on oleuropein's antioxidant and bone-supportive actions.

Bonolive is researched primarily for Bone Health and Joint Health. Oleuropein-rich olive leaf extract is studied for supporting bone-forming activity and bone mineral density, particularly in postmenopausal women at risk of bone loss.

The clinically studied dose is About 250 mg per day, providing a standardized oleuropein dose. Always follow the product label and check with a healthcare provider for personal advice.

For most healthy adults, Bonolive is well tolerated at studied doses. Reported effects can include: Generally well-tolerated — olive leaf extract is well tolerated. Mild digestive upset is occasionally reported. It may also interact with some medications. Bonolive is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Possible interactions include: Blood pressure medication — olive leaf may have a mild additive lowering effect; monitor. Diabetes medication — may affect blood sugar; watch levels. If you take prescription medication, check with a pharmacist or doctor before using it.

NutraSmarts rates the evidence for Bonolive as Moderate (3 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.